Pruritus and quality of life in moderate‐to‐severe plaque psoriasis: <i>post hoc</i> explorative analysis from the <scp>PRISTINE</scp> study

Abstract

Most patients with moderate-to-severe psoriasis in this study (96%) reported pruritus. Pruritus improved significantly with ETN therapy and was strongly associated with improvements in QoL. These data support the clinical relevance of pruritus as an important symptom of patients with moderate/severe psoriasis.